Abstract
Aspergillus infection is relatively rare disease, and we present a case of orbital aspergillus infection who presented with right orbital pain and swelling. Right orbital lesion was identified on CT, MRI, and PET-CT imaging followed by confirmation of aspergillus on histopathological examination. We demonstrate that Tc-99 m ubiquicidin scan can yield positive results in aspergillosis too, enabling its differentiation from non-infective pathologies.
This is a preview of subscription content, log in via an institution to check access.
Data Availability
Contact the corresponding author for data requests.
References
Douglas AP, Smibert Olivia C, Bajel A, Halliday CL, Lavee O, McMullan B, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Int Med J. 2021;51:143–76.
Adulkar NG, Radhakrishnan S, Vidhya N, Kim U. Invasive sino-orbital fungal infections in immunocompetent patients: a clinico-pathological study. Eye (Lond). 2019;33:988–94.
Ferro-Flores G, Arteaga de Murphy C, Pedraza-López M, Meléndez-Alafort L, Zhang Y-M, Rusckowski M, et al. In vitro and in vivo assessment of 99mTc-UBI specificity for bacteria. Nucl Med Biol. 2003;30:597–603.
Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M, et al. Antimicrobial peptide 99mTc-ubiquicidin 29–41 as human infection-imaging agent: clinical trial. J Nucl Med. 2005;46:567–73.
Ostovar A, Assadi M, Vahdat K, Nabipour I, Javadi H, Eftekhari M, et al. A pooled analysis of diagnostic value of (99m)Tc-ubiquicidin (UBI) scintigraphy in detection of an infectious process. Clin Nucl Med. 2013;38:413–6.
Aryana K, Hootkani A, Sadeghi R, Davoudi Y, Naderinasab M, Erfani M, et al. (99m)Tc-labeled ubiquicidin scintigraphy: a promising method in hip prosthesis infection diagnosis. Nuklearmedizin. 2012;51:133–9.
Ghahremani S, Sadeghi R, Dabbagh Kakhki VR, Massoudi T, Aryana K. 99mTc-Labeled ubiquicidin accumulation in a retained surgical gauze. Clin Nucl Med. 2016;41:941–3.
Vallejo E, Martinez I, Tejero A, Hernandez S, Jimenez L, Bialostozky D, et al. Clinical utility of 99mTc-labeled ubiquicidin 29–41 antimicrobial peptide for the scintigraphic detection of mediastinitis after cardiac surgery. Arch Med Res. 2008;39:768–74.
Nazari B, Azizmohammadi Z, Rajaei M, Karami M, Javadi H, Assadi M, et al. Role of 99mTc-ubiquicidin 29–41 scintigraphy to monitor antibiotic therapy in patients with orthopedic infection: a preliminary study. Nucl Med Commun. 2011;32:745–51.
Ayati N, Norouzi M, Sadeghi R, Erfani M, Gharedaghi M, Aryana K. Diagnostic value of 99mTc-ubiquicidin scintigraphy in differentiation between osteomyelitis and bone tumors. Nucl Med Commun. 2017;38(11):885–90.
Beiki D, Yousefi G, Fallahi B, Tahmasebi MN, Gholamrezanezhad A, Fard-Esfahani A, Erfani M, Eftekhari M. (99m)tc-Ubiquicidin [29–41], a promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation. Iran J Pharm Res. 2013 Spring;12(2):347–53
Acknowledgements
The authors acknowledge ICMR (Indian Council of Medical Research) for the fund support.
Funding
Funding received from ICMR (Indian Council of Medical Research) for the project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Meivel Angamuthu, Nishikant Damle, Dikhra Khan, Rachna Meel, Sanjay Sharma, and Chandrasekhar Bal declare no conflict of interest.
Ethical Statement
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent from the patient was obtained to be included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Angamuthu, M., Damle, N., Khan, D. et al. Tc-99 m Ubiquicidin Imaging in Orbital Aspergilloma: an Illustration. Nucl Med Mol Imaging 57, 162–163 (2023). https://doi.org/10.1007/s13139-022-00784-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-022-00784-0